These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 18226731)

  • 1. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Some issues in the diagnosis and treatment of hyperprolactinemia].
    Jin ZM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
    Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
    Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on prolactinomas. Part 2: Treatment and management strategies.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia: etiology, diagnosis, and management.
    Mah PM; Webster J
    Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin-secreting tumors: what's new?
    Molitch ME
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S29-35. PubMed ID: 17004854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin in men's health and disease.
    Bolyakov A; Paduch DA
    Curr Opin Urol; 2011 Nov; 21(6):527-34. PubMed ID: 21941183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia in children: clinical features and long-term results.
    Catli G; Abaci A; Altincik A; Demir K; Can S; Buyukgebiz A; Bober E
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1123-8. PubMed ID: 23329759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.
    Casanueva FF; Molitch ME; Schlechte JA; Abs R; Bonert V; Bronstein MD; Brue T; Cappabianca P; Colao A; Fahlbusch R; Fideleff H; Hadani M; Kelly P; Kleinberg D; Laws E; Marek J; Scanlon M; Sobrinho LG; Wass JA; Giustina A
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):265-73. PubMed ID: 16886971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.
    Mascarell S; Sarne DH
    Pituitary; 2007; 10(1):95-101. PubMed ID: 17308959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinaemia.
    Patel SS; Bamigboye V
    J Obstet Gynaecol; 2007 Jul; 27(5):455-9. PubMed ID: 17701788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia and infertility.
    Shibli-Rahhal A; Schlechte J
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):837-46. PubMed ID: 22108283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of prolactinomas during pregnancy.
    Witek P; Zieliński G
    Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia].
    Halperin Rabinovich I; Cámara Gómez R; García Mouriz M; Ollero García-Agulló D;
    Endocrinol Nutr; 2013; 60(6):308-19. PubMed ID: 23477758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.